Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience

CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis for both locally advanced and metastatic disease. Standard treatment with combination etoposide–doxorubicin–cisplatin–mitotane (EDP-M) is highly toxic and some patients benefit from mitotane monotherapy. However, identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnon, Johnathan, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Gross, David J, Salmon, Asher, Meirovitz, Amichay, Maimon, Ofra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354968/
https://www.ncbi.nlm.nih.gov/pubmed/35949453
http://dx.doi.org/10.1210/jendso/bvac112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354968/
https://www.ncbi.nlm.nih.gov/pubmed/35949453
http://dx.doi.org/10.1210/jendso/bvac112

Ejemplares similares